Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Health Canada has informed Canadians of a possible link between Baraclude [entecavir] and the development of a treatment-resistant HIV strain

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Health Canada.Health Canada examining information linking antiviral drug to development of treatment-resistant HIV. Media Release: 21 Feb 2007. Available from: URL: http://www.hc-sc.gc.ca

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Health Canada has informed Canadians of a possible link between Baraclude [entecavir] and the development of a treatment-resistant HIV strain. React. Wkly. 1141, 2 (2007). https://doi.org/10.2165/00128415-200711410-00004

    Download citation

    Keywords

    • Public Health
    • Entecavir
    • Virus Level
    • Safety Recommendation
    • Baraclude